Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment
Authors
Keywords
-
Journal
MOLECULES
Volume 23, Issue 11, Pages 2906
Publisher
MDPI AG
Online
2018-11-09
DOI
10.3390/molecules23112906
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- cRGD functionalised nanocarriers for targeted delivery of bioactives
- (2018) K. R. Gajbhiye et al. JOURNAL OF DRUG TARGETING
- iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability
- (2017) Fei Gao et al. International Journal of Nanomedicine
- Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery
- (2017) Jia-Lin Huang et al. JOURNAL OF DRUG TARGETING
- Co-delivery of hydrophilic gemcitabine and hydrophobic paclitaxel into novel polymeric micelles for cancer treatment
- (2017) Yan Di et al. RSC Advances
- Exploring the Role of RGD-Recognizing Integrins in Cancer
- (2017) Markus Nieberler et al. Cancers
- Cost-Utility of "Doxorubicin and Cyclophosphamide" versus "Gemcitabine and Paclitaxel" for Treatment of Patients with Breast Cancer in Iran
- (2016) Nahid Hatam et al. Asian Pacific Journal of Cancer Prevention
- Incidence and Mortality and Epidemiology of Breast Cancer in the World
- (2016) Mahshid Ghoncheh et al. Asian Pacific Journal of Cancer Prevention
- Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment
- (2016) DongMei Yu et al. BIOMEDICINE & PHARMACOTHERAPY
- The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate
- (2016) Xiang Li et al. International Journal of Nanomedicine
- Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line
- (2016) Xinzhe Yu et al. Scientific Reports
- Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy
- (2016) Chandran Murugan et al. Scientific Reports
- Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice
- (2015) Huan Meng et al. ACS Nano
- Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer
- (2015) Ilkoo Noh et al. BIOMATERIALS
- Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?
- (2015) Michelle M. Williams et al. Oncotarget
- Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer
- (2014) Lei Miao et al. ADVANCED FUNCTIONAL MATERIALS
- Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer
- (2014) Ping Chen et al. CANCER SCIENCE
- Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model
- (2014) Jing Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates
- (2014) R. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumour targeting of lipid nanocapsules grafted with cRGD peptides
- (2013) Samuli Hirsjärvi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The Functions and Applications of RGD in Tumor Therapy and Tissue Engineering
- (2013) Fen Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02
- (2013) Yeon Hee Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSCLC
- (2013) Yuan Zhang et al. MOLECULAR THERAPY
- Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles
- (2011) Sandy Vrignaud et al. BIOMATERIALS
- PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration
- (2011) Ganta Chaitanya et al. Cell Communication and Signaling
- In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles
- (2011) Brian R. Sloat et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Mechanism of Inactivation of Human Ribonucleotide Reductase with p53R2 by Gemcitabine 5′-Diphosphate
- (2009) Jun Wang et al. BIOCHEMISTRY
- Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery
- (2009) Jun Li et al. JOURNAL OF CONTROLLED RELEASE
- Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment
- (2008) Kathy S. Albain et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now